Background illustration for clinical trials search

Paid Clinical Trials Dayton

Discover 1,190 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Triamcinolone With Vitamin D Synergistic Efficacy in Psoriasis

for
Plaque Psoriasis, Vitamin D3
Location: Fairborn OH
Sponsor: Wright State University

Sex: All

Age: 18+

Code: NCT04036188

Early Phase 1, Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Beavercreek OH, Indianapolis IN, Northville MI,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

A Prospective Longitudinal Analysis of Faricimab (Vabysmo 6mg) For Choroidal Neovascularization in Presumed Ocular Histoplasmosis Syndrome

for
Presumed Ocular Histoplasmosis
Location: Dayton OH, Cincinnati OH
Sponsor: Cincinnati Eye Institute, Southwest Ohio

Sex: All

Age: 18+

Code: NCT07695298

Recruiting

A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uricase Failure Gout Participants

for
Gout
Location: Dayton OH, Lexington KY, Sterling Heights MI, Troy MI,
Sponsor: Crystalys Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT07535034

Phase 2, Recruiting

[18F]PI-2620 Phase 3 Histopathological Study

for
Alzheimer Disease
Location: Centerville OH, Beachwood OH, Syracuse NY, Braintree MA,
Sponsor: Lantheus Biosciences Ltd.

Sex: All

Age: 50+

Code: NCT05641688

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Evaluation of Hearing Protection Fit Testing Program

for
Hearing Loss
Location: Dayton OH, Elemendorf Air Force Base AK
Sponsor: United States Air Force

Sex: All

Age: 0+

Code: NCT02109757

Recruiting

Adjustment Disorders in the US Military: Disease Trajectories and ADNM-20-Mil Validation

for
Adjustment Disorders
Location: Wright-Patterson Air Force Base OH, Fort Sam Houston TX,
Sponsor: Henry M. Jackson Foundation for the Advancement of Military Medicine

Sex: All

Age: 18 - 64

Code: NCT06885554

Recruiting

Study of LHP588 in Subjects With P. Gingivalis-Positive Alzheimer's Disease

for
Alzheimer Disease, Alzheimer Disease Due to P. Gingivalis
Location: Dayton OH, Nashville TN, Charlottesville VA,
Sponsor: Lighthouse Pharmaceuticals, Inc.

Sex: All

Age: 55 - 70+

Code: NCT06847321

Phase 2, Recruiting

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

for
Breast Cancer
Location: Centerville OH, Fairfield OH, Louisville KY,
Sponsor: Stemline Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06492616

Phase 3, Recruiting

A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer

for
Ovarian Neoplasms, Fallopian Tube Neoplasms,
Location: Centerville OH, Cincinnati OH, Hilliard OH, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT07213804

Phase 3, Recruiting

A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer

for
Endometrial Cancer
Location: Centerville OH, Hilliard OH, Lexington KY, Urbana IL,
Sponsor: BioNTech SE

Sex: Female

Age: 18+

Code: NCT06340568

Phase 3, Recruiting

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

for
Colon Adenocarcinoma, Rectal Adenocarcinoma
Location: Centerville OH, Cincinnati OH, Lexington KY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06997497

Phase 3, Recruiting

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

for
Endometrial Adenocarcinoma,
Location: Centerville OH, Columbus OH, Indianapolis IN,
Sponsor: National Cancer Institute (NCI)

Sex: Female

Age: 18+

Code: NCT05112601

Phase 2, Recruiting

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

for
Leukemia, Myeloid, Acute
Location: Centerville OH, Cincinnati OH, Lexington KY,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06852222

Phase 3, Recruiting

Study to Assess the Efficacy and Safety of Rina-S Plus Standard of Care Compared to Standard of Care for Maintenance Treatment of Participants With Recurrent Platinum-sensitive Ovarian Cancer After Second-line (2L) Platinum-based Doublet Chemotherapy

for
Ovarian Cancer, Platinum-sensitive Ovarian Cancer, PSOC
Location: Centerville OH, Columbus OH, Charlotte NC, Towson MD,
Sponsor: Genmab

Sex: Female

Age: 18+

Code: NCT07225270

Phase 3, Recruiting

Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma

for
Cutaneous Melanoma, Stage II
Location: Centerville OH, West Chester OH, Cincinnati OH,
Sponsor: Melanoma and Skin Cancer Trials Limited

Sex: All

Age: 18+

Code: NCT03860883

Recruiting

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

for
Liver Neoplasms, Primary Liver Cancer, Secondary Liver Cancer,
Location: Centerville OH, Columbus OH, Cleveland OH, Detroit MI,
Sponsor: HistoSonics, Inc.

Sex: All

Age: 22+

Code: NCT06486454

Recruiting

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung
Location: Centerville OH, Columbus OH, Indianapolis IN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06890598

Phase 3, Recruiting

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

for
Ovarian Cancer
Location: Centerville OH, Indianapolis IN, Ann Arbor MI,
Sponsor: Daiichi Sankyo

Sex: Female

Age: 18+

Code: NCT06819007

Phase 3, Recruiting

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

for
Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis
Location: Centerville OH, Cincinnati OH, Columbus OH,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06119581

Phase 3, Recruiting